Aleny Couto
Overview
Explore the profile of Aleny Couto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
310
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ismael N, Hussein C, Magul C, Inguane H, Couto A, Nhangave A, et al.
Pathogens
. 2025 Jan;
14(1).
PMID: 39861009
Real-world data on HIV drug resistance (HIVDR) after transitioning to tenofovir disoproxil fumarate/lamivudine/dolutegravir (TLD) are limited. We assessed HIVDR rates and patterns in clients with virological failure (VF) after switching...
2.
Mendes-Muxlhanga A, Nhacolo A, Figueroa-Romero A, Mazuze M, Mayor A, Vala A, et al.
BMC Public Health
. 2025 Jan;
25(1):251.
PMID: 39838327
Background: Monitoring HIV infection estimates is critical to guide health interventions and assess their impact, especially in highly vulnerable groups to the infection such as African pregnant women. This study...
3.
Teasdale C, Choy M, Tsiouris F, De Gusmao E, Banqueiro E, Couto A, et al.
PLoS One
. 2024 Dec;
19(12):e0315047.
PMID: 39625938
[This corrects the article DOI: 10.1371/journal.pone.0283558.].
4.
Cuboia N, Mutaquiha C, Manhica I, Jose B, Amaro M, Pfumo-Cuboia I, et al.
Trop Med Int Health
. 2024 Nov;
29(12):1051-1061.
PMID: 39587324
Introduction: Mozambique is among the highest-burden countries for drug-resistant tuberculosis in the world. However, the spatial distribution of drug-resistant tuberculosis, in the country is unknown. Therefore, we aimed to analyse...
5.
Mudender F, Paredes Z, Maiela A, Vio F, Amane G, Mamudo A, et al.
Sci Rep
. 2024 Sep;
14(1):21736.
PMID: 39289479
The HIV prevalence in Maputo city is 16.2%. There is a lack of data describing associated factors with disclosure or non-disclosure of HIV-positive sero-status to sexual partners. This analysis describes...
6.
Viisainen K, Baumgart Dos Santos M, Sunderbrink U, Couto A
PLOS Glob Public Health
. 2024 Jul;
4(7):e0003166.
PMID: 39008454
Both gender and HIV stigma are known to contribute to poor retention to antiretroviral therapy (ART), but little is known how they interact in decisions about adherence or default by...
7.
De Schacht C, Lucas C, Paulo P, Naftal Fernando A, Ernesto Chinai J, Silva W, et al.
PLoS One
. 2024 Jun;
19(6):e0305391.
PMID: 38885228
Background: In 2021, Mozambique initiated community-based oral HIV self-testing (HIVST) to increase testing access and uptake among priority groups, including adult males, adolescents, and young adults. Within an HIVST pilot...
8.
Moiana Uetela D, Zimmermann M, Chicumbe S, Gudo E, Barnabas R, Uetela O, et al.
J Int AIDS Soc
. 2024 May;
27(5):e26275.
PMID: 38801731
Introduction: In 2018, the Mozambique Ministry of Health launched guidelines for implementing differentiated service delivery models (DSDMs) to optimize HIV service delivery, improve retention in care, and ultimately reduce HIV-associated...
9.
Saura-Lazaro A, Augusto O, Fernandez-Luis S, Lopez-Varela E, Fuente-Soro L, Bila D, et al.
AIDS
. 2024 Apr;
38(9):1402-1411.
PMID: 38652496
Objective: Evaluate the effect of three multimonth dispensing (3MMD) of antiretroviral therapy (ART) on HIV care retention in southern Mozambique. Design: Retrospective cohort study. Methods: We analyzed routine health data...
10.
Buck W, Schindele A, Taibo E, Perez P, Deus M, Matsinhe M, et al.
J Int AIDS Soc
. 2024 Jan;
27(1):e26203.
PMID: 38193651
No abstract available.